Published in Clin Exp Immunol on July 01, 1994
Receptor recruitment: a mechanism for interactions between G protein-coupled receptors. Proc Natl Acad Sci U S A (1999) 0.97
Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis. Clin Exp Immunol (2000) 0.82
Localization of alpha 1-adrenoceptors in rat and human hearts by immunocytochemistry. Mol Cell Biochem (1997) 0.77
Doxazosin attenuates renal matrix remodeling mediated by anti-α1-adrenergic receptor antibody in a rat model of diabetes mellitus. Exp Ther Med (2017) 0.75
Inositol trisphosphate and diacylglycerol as second messengers. Biochem J (1984) 14.37
Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc Natl Acad Sci U S A (1988) 3.18
Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J Biol Chem (1991) 2.35
Molecular mechanisms involved in alpha-adrenergic responses. Mol Cell Endocrinol (1981) 2.12
Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. Eur J Biochem (1991) 1.74
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1993) 1.51
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin Exp Immunol (1989) 1.07
New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance. Am Heart J (1988) 0.98
Photoaffinity labeling of mammalian alpha 1-adrenergic receptors. Identification of the ligand binding subunit with a high affinity radioiodinated probe. J Biol Chem (1984) 0.98
Molecular cloning and sequencing of a cDNA encoding a human alpha 1A adrenergic receptor. Biochem Biophys Res Commun (1991) 0.93
Beta 2-adrenergic receptor antibodies in myasthenia gravis. J Autoimmun (1992) 0.91
Immunocytochemical localization of M2 muscarinic receptors in rat ventricles with anti-peptide antibodies. J Histochem Cytochem (1994) 0.89
Cholinergic and adrenergic receptors on mouse cardiocytes in vitro. Dev Biol (1977) 0.89
Functional analysis of rabbit anti-peptide antibodies which mimic autoantibodies against the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Autoimmun (1991) 0.88
Effect of metoprolol on activity of beta-adrenoceptor coupled to guanine nucleotide binding regulatory proteins in adriamycin-induced cardiotoxicity. Basic Res Cardiol (1991) 0.84
Haplotype specific homology scanning algorithm to predict T-cell epitopes from protein sequences. J Mol Recognit (1991) 0.81
Induction of a pharmacologically active clonotypic B cell response directed to an immunogenic region of the human beta 2-adrenergic receptor. Clin Exp Immunol (1992) 0.80
Subunit structure of rat liver alpha 1 adrenergic receptor. Biochem Pharmacol (1982) 0.78
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet (1993) 3.20
Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation (1991) 2.97
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J (1975) 2.71
The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med (2000) 2.62
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57
Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. Biochem Biophys Res Commun (1976) 2.29
Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation (1989) 2.24
Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation (1997) 2.16
Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med (2001) 2.07
A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J (2000) 1.96
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J (1980) 1.85
Beta-blockers and sudden cardiac death. Ann Intern Med (1995) 1.83
Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol (2001) 1.80
Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc (1973) 1.66
Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation (1997) 1.64
The appropriateness of performing coronary angiography and coronary artery revascularization in a Swedish population. JAMA (1994) 1.64
Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation (1994) 1.63
Immunoperoxidase visualisation of microtubules and microtubular proteins. Nature (1976) 1.56
Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol (2001) 1.55
Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet (1979) 1.55
Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J (1992) 1.55
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1993) 1.51
Female sex is associated with increased mortality and morbidity early, but not late, after coronary artery bypass grafting. Eur Heart J (1996) 1.51
Prognosis of acute myocardial infarction in diabetic and non-diabetic patients. Diabet Med (1993) 1.47
Eligibility for intravenous thrombolysis in suspected acute myocardial infarction. Circulation (1990) 1.46
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci (2000) 1.42
Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes. Int J Cardiol (1999) 1.40
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med (2003) 1.39
Evidence for reversible microclustering of lentil lectin membrane receptors on HeLa cells. FEBS Lett (1980) 1.34
Immunomodulatory properties of cystatins. Cell Mol Life Sci (2002) 1.34
Distress correlates with the degree of chest pain: a description of patients awaiting revascularisation. Heart (1996) 1.30
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens (2000) 1.26
The human carcinoma cell line A431 possesses large numbers of functional beta-adrenergic receptors. FEBS Lett (1984) 1.25
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med (1995) 1.23
Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation (2000) 1.22
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol (2000) 1.18
Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension (1997) 1.18
Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation (1996) 1.14
Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation (2001) 1.14
Effect of acupuncture in patients with angina pectoris. Eur Heart J (1991) 1.14
Characterization, serological specificity, and diagnostic possibilities of monoclonal antibodies against Legionella pneumophila. J Clin Microbiol (1983) 1.12
Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room. Am J Cardiol (1991) 1.12
Patients admitted to the emergency room with symptoms indicative of acute myocardial infarction. J Intern Med (1991) 1.12
Are patients truthful about their smoking habits? A validation of self-report about smoking cessation with biochemical markers of smoking activity amongst patients with ischaemic heart disease. J Intern Med (2001) 1.11
beta-Adrenergic agonist activity of a monoclonal anti-idiotypic antibody. Proc Natl Acad Sci U S A (1985) 1.11
Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res (2001) 1.10
Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci U S A (1997) 1.10
Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart J (1980) 1.10
Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg (1999) 1.10
The production and characterization of antibodies against beta-adrenergic antagonists. Biochem Pharmacol (1978) 1.09
Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J Immunol (1996) 1.08
Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents. Br Heart J (1979) 1.07
Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin Exp Immunol (1989) 1.07
A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med (1983) 1.06
Redistribution of muscarinic acetylcholine receptors on human fibroblasts induced by regulatory ligands. Biol Cell (1987) 1.06
Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation (1989) 1.05
In vitro work load and rat heart metabolism. I. Effect on protein synthesis. Acta Physiol Scand (1972) 1.05
Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J Biol Chem (1996) 1.05
Epitopic analysis of the Toxoplasma gondii major surface antigen SAG1. Mol Biochem Parasitol (1994) 1.04
Complications prior to revascularization among patients waiting for coronary artery bypass grafting and percutaneous transluminal coronary angioplasty. Eur Heart J (1996) 1.04
Quality of life five years after myocardial infarction. Eur Heart J (1989) 1.04
Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab (2006) 1.04
Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol (2000) 1.04
Effects of levamisole on spontaneous rosette-forming cells in murine spleen. Eur J Immunol (1976) 1.01
Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy. J Thorac Cardiovasc Surg (2000) 1.01
Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol (1997) 1.00
Effect of temperature and pressure on polymerisation equilibrium of neuronal microtubules. Nature (1976) 1.00
The epidemiology of a coronary waiting list. A description of all of the patients. J Intern Med (1994) 1.00
Age and sex differences in cardiovascular reactivity to adrenergic agonists, mental stress and isometric exercise in normal subjects. Scand J Clin Lab Invest (1988) 1.00
Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med (Berl) (2000) 0.99
Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol (1994) 0.99
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial. Am Heart J (2001) 0.99
High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardiol (1995) 0.98
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure. Heart (2003) 0.98
Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and non-myocytes. Pflugers Arch (2003) 0.98
The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation (1983) 0.98
Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy. Autoimmunity (2000) 0.97
Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells. Cell Death Differ (2006) 0.97
Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat Med (1999) 0.96
From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists. Mol Pharmacol (2000) 0.96
Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand (1988) 0.95